专栏名称: 毕凯今选
由毕凯医药为您每周跟踪PUBMED十大瘤种最新前沿进展,编译制作,每日分享推送,希望我们的一点点绵薄之力,能为临床助力,做医生的朋友,做患者的帮助!
目录
相关文章推荐
BioArt  ·  Cell | ... ·  2 天前  
BioArt  ·  Nat Cell Biol | ... ·  3 天前  
生物探索  ·  Nature | ... ·  4 天前  
今天看啥  ›  专栏  ›  毕凯今选

【其他高分选 061】

毕凯今选  · 公众号  ·  · 2024-08-27 15:43
    

文章预览

BC PMID: 39178356 IF:42.1 Social Genomic Determinants of Health: Understanding the Molecular Pathways by Which Neighborhood Disadvantage Affects Cancer Outcomes SCI:J Clin Oncol PMID:39180380 IF:10.9 The recent advance and prospect of poly(ADP-ribose) polymerase inhibitors for the treatment of cancer SCI:Med Res Rev PMID:39179659 IF:81.1 Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer SCI:Nat Rev Clin Oncol PMID:39186778 IF:12.5 A Dual-Payload Antibody-Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer SCI:Cancer Res PMID:39186674 IF:12.5 CRISPR Screening of Transcribed Super-Enhancers Identifies Drivers of Triple-Negative Breast Cancer Progression SCI:Cancer Res PMID:39186665 IF:12.5 Low Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer SCI:Cancer Res PMID:39186297 IF:22.5 Evaluating Supplemental Breast Cancer Screening With Simula ………………………………

原文地址:访问原文地址
快照地址: 访问文章快照
总结与预览地址:访问总结与预览